A novel immune model predicts the prognosis of mantle cell lymphoma | Synapse
March 3, 2026Open Access
A novel immune model predicts the prognosis of mantle cell lymphoma
Key Points
The novel immune model enhances prognostic evaluation for mantle cell lymphoma patients.
Incorporating immune factors and clinical features, it offers a comprehensive assessment.
Developed specifically for mantle cell lymphoma, this model aims to guide treatment strategies.
Highlights the need for improved prognostic tools in evaluating lymphoma outcomes.
Abstract
This study developed an innovative immune prognostic model for evaluating the prognosis of MCL patients, integrating immune factors with existing clinical features to improve prognostic evaluation.